Clinical studies have shown that patients using Tirzepatide can lose between 12 25 pounds, making it an ideal option for those who have struggled to lose weight with other treatments, such as Semaglutide
With Jeff Atlas, PA-C leading your treatment and Dr
T2DM accounts for more than 90% of all diabetes cases , with approximately 589 million adults aged 20-79 affected worldwide in 2024
So first the trial and Im just going to cut and paste from Lillys pressor on this part as to what the trial actually is: TRIUMPH-4 (NCT05869903) is a Phase 3, 68-week, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of retatrutide with placebo in adults with obesity or overweight and knee osteoarthritis
LANSING, Mich
For UK medicines regulation context, the MHRA is the authoritative source